Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)
| Autor: | Rochlitz, C. *, Ruhstaller, T., Lerch, S., Spirig, C., Huober, J., Suter, T., Bühlmann, M., Fehr, M., Schönenberger, A., von Moos, R., Winterhalder, R., Rauch, D., Müller, A., Mannhart-Harms, M., Herrmann, R., Cliffe, B., Mayer, M., Zaman, K. |
|---|---|
| Zdroj: | In Annals of Oncology January 2011 22(1):80-85 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|